ID

31556

Description

A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00564928

Link

https://clinicaltrials.gov/show/NCT00564928

Keywords

Versions (1)
  1. 9/4/18 9/4/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 4, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT00564928

English

Eligibility Prostate Cancer NCT00564928

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adenocarcinoma of the prostate
Description

Adenocarcinoma of prostate

Data type

boolean

Alias
UMLS CUI [1]
C0007112
resolution of acute toxic side effects of prior chemotherapy
Description

Prior Chemotherapy | Resolution Side effects Toxic

Data type

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C1514893
UMLS CUI [2,2]
C0879626
UMLS CUI [2,3]
C1407029
castration resistant disease despite ongoing chemical or surgical castration
Description

Disease Resistant to Castration | Chemical male castration | Male Castration

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332325
UMLS CUI [1,3]
C0007347
UMLS CUI [2]
C0455189
UMLS CUI [3]
C0007347
ecog 0-1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
psa greater than or equal to 2
Description

Prostate specific antigen measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201544
group a -
Description

Group Roman letter

Data type

boolean

Alias
UMLS CUI [1,1]
C0441833
UMLS CUI [1,2]
C0439102
no prior treatment for prostate cancer with cytotoxic chemotherapy (neoadjuvant, adjuvant treatment permitted if more than 2 years out)
Description

Cytotoxic Chemotherapy Absent Prostate carcinoma | Neoadjuvant Therapy allowed | Adjuvant therapy allowed

Data type

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0600139
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C0683607
UMLS CUI [3,1]
C0677850
UMLS CUI [3,2]
C0683607
group b
Description

Group Roman letter

Data type

boolean

Alias
UMLS CUI [1,1]
C0441833
UMLS CUI [1,2]
C0439102
radiographic evidence of metastatic disease
Description

Neoplasm Metastasis Radiography

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0034571
prior tx with docetaxel-minimum of 2 cycles with progression by recist or psa or intolerant of tx
Description

Docetaxel Course Quantity Minimum | Disease Progression Prostate specific antigen measurement | Intolerance Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C0246415
UMLS CUI [1,2]
C0750729
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C1524031
UMLS CUI [2,1]
C0242656
UMLS CUI [2,2]
C0201544
UMLS CUI [3,1]
C0231199
UMLS CUI [3,2]
C0087111
maximum of 3 prior chemotherapies
Description

Prior Chemotherapy Quantity Maximum

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0806909
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
small cell carcinoma of the prostate
Description

Small cell carcinoma of prostate

Data type

boolean

Alias
UMLS CUI [1]
C1300585
treatment within 2 weeks with approved, investigational, or small molecule
Description

Molecule Treatment Approved | Molecule Treatment Investigational | Small Molecule Treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C0567416
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205540
UMLS CUI [2,1]
C0567416
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C1517586
UMLS CUI [3,1]
C1328819
UMLS CUI [3,2]
C0087111
treatment within 4 weeks with biologic or external beam radiation
Description

Biological treatment | External beam radiotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1531518
UMLS CUI [2]
C0419095
anc <1,500 cells m3; platelets <100,000 mm3; hemoglobin <9.0g/dl
Description

Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0518015
ast/alt >2.5 uln
Description

Aspartate aminotransferase increased | Alanine aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
serum creatinine >3.0mg/dl
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
active keratitis or keratoconjunctivitis
Description

Keratitis | Keratoconjunctivitis

Data type

boolean

Alias
UMLS CUI [1]
C0022568
UMLS CUI [2]
C0022573
previous treatment with 17-aag, dmag; or any other hsp-90 inhibitor
Description

17-AAG | 17-DMAG | HSP90 Inhibitors

Data type

boolean

Alias
UMLS CUI [1]
C0675974
UMLS CUI [2]
C1527262
UMLS CUI [3,1]
C0243044
UMLS CUI [3,2]
C0243077
baseline qtc >450 mses
Description

Prolonged QTc

Data type

boolean

Alias
UMLS CUI [1]
C1969409
Back to the top of the page

Similar models

Eligibility Prostate Cancer NCT00564928

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Prior Chemotherapy | Resolution Side effects Toxic
Item
resolution of acute toxic side effects of prior chemotherapy
boolean
C1514457 (UMLS CUI [1])
C1514893 (UMLS CUI [2,1])
C0879626 (UMLS CUI [2,2])
C1407029 (UMLS CUI [2,3])
Disease Resistant to Castration | Chemical male castration | Male Castration
Item
castration resistant disease despite ongoing chemical or surgical castration
boolean
C0012634 (UMLS CUI [1,1])
C0332325 (UMLS CUI [1,2])
C0007347 (UMLS CUI [1,3])
C0455189 (UMLS CUI [2])
C0007347 (UMLS CUI [3])
ECOG performance status
Item
ecog 0-1
boolean
C1520224 (UMLS CUI [1])
Prostate specific antigen measurement
Item
psa greater than or equal to 2
boolean
C0201544 (UMLS CUI [1])
Group Roman letter
Item
group a -
boolean
C0441833 (UMLS CUI [1,1])
C0439102 (UMLS CUI [1,2])
Cytotoxic Chemotherapy Absent Prostate carcinoma | Neoadjuvant Therapy allowed | Adjuvant therapy allowed
Item
no prior treatment for prostate cancer with cytotoxic chemotherapy (neoadjuvant, adjuvant treatment permitted if more than 2 years out)
boolean
C0677881 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C0600558 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
C0677850 (UMLS CUI [3,1])
C0683607 (UMLS CUI [3,2])
Group Roman letter
Item
group b
boolean
C0441833 (UMLS CUI [1,1])
C0439102 (UMLS CUI [1,2])
Neoplasm Metastasis Radiography
Item
radiographic evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1,1])
C0034571 (UMLS CUI [1,2])
Docetaxel Course Quantity Minimum | Disease Progression Prostate specific antigen measurement | Intolerance Therapeutic procedure
Item
prior tx with docetaxel-minimum of 2 cycles with progression by recist or psa or intolerant of tx
boolean
C0246415 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1524031 (UMLS CUI [1,4])
C0242656 (UMLS CUI [2,1])
C0201544 (UMLS CUI [2,2])
C0231199 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
Prior Chemotherapy Quantity Maximum
Item
maximum of 3 prior chemotherapies
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0806909 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Small cell carcinoma of prostate
Item
small cell carcinoma of the prostate
boolean
C1300585 (UMLS CUI [1])
Molecule Treatment Approved | Molecule Treatment Investigational | Small Molecule Treatment
Item
treatment within 2 weeks with approved, investigational, or small molecule
boolean
C0567416 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205540 (UMLS CUI [1,3])
C0567416 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C1517586 (UMLS CUI [2,3])
C1328819 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
Biological treatment | External beam radiotherapy
Item
treatment within 4 weeks with biologic or external beam radiation
boolean
C1531518 (UMLS CUI [1])
C0419095 (UMLS CUI [2])
Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
anc <1,500 cells m3; platelets <100,000 mm3; hemoglobin <9.0g/dl
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
ast/alt >2.5 uln
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Creatinine measurement, serum
Item
serum creatinine >3.0mg/dl
boolean
C0201976 (UMLS CUI [1])
Keratitis | Keratoconjunctivitis
Item
active keratitis or keratoconjunctivitis
boolean
C0022568 (UMLS CUI [1])
C0022573 (UMLS CUI [2])
17-AAG | 17-DMAG | HSP90 Inhibitors
Item
previous treatment with 17-aag, dmag; or any other hsp-90 inhibitor
boolean
C0675974 (UMLS CUI [1])
C1527262 (UMLS CUI [2])
C0243044 (UMLS CUI [3,1])
C0243077 (UMLS CUI [3,2])
Prolonged QTc
Item
baseline qtc >450 mses
boolean
C1969409 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial